Yiting Wang Selected Research

Hepatocellular Carcinoma (Hepatoma)

11/2022	Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
1/2022	Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells.
10/2015	Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
1/2015	CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiting Wang Research Topics

Disease

46	Neoplasms (Cancer) 12/2024 - 11/2007
17	Inflammation (Inflammations) 03/2024 - 01/2019
16	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2016
13	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 01/2018
13	Chronic Kidney Failure (Chronic Renal Failure) 02/2023 - 01/2018
11	Proteinuria 12/2023 - 07/2018
10	Fibrosis (Cirrhosis) 12/2023 - 01/2018
9	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2018
7	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2007
7	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 10/2014
7	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 12/2009
5	COVID-19 04/2024 - 01/2022
5	Infections 04/2024 - 08/2021
5	Pain (Aches) 03/2024 - 01/2021
5	Atrophy 12/2023 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 11/2004
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2007
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 06/2017
4	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2015
4	Chronic Renal Insufficiency 08/2019 - 07/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2017
3	Obesity 01/2024 - 11/2007
3	Tuberculosis (Tuberculoses) 12/2023 - 01/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2020
3	Leukemia 01/2023 - 05/2021
3	Carcinogenesis 01/2023 - 04/2020
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2017
3	Colonic Neoplasms (Colon Cancer) 04/2020 - 11/2015
3	Hypertension (High Blood Pressure) 08/2019 - 01/2019
3	Glioma (Gliomas) 01/2019 - 05/2018
2	Postoperative Pain 03/2024 - 01/2023
2	Insulin Resistance 01/2024 - 01/2023
2	Lymphatic Metastasis 01/2024 - 07/2023
2	Dehydration (Water Stress) 12/2023 - 03/2023
2	Visceral Pain 11/2023 - 01/2023
2	Thrombosis (Thrombus) 10/2023 - 11/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2023 - 11/2021
2	Hypoxia (Hypoxemia) 10/2023 - 01/2023
2	Body Weight (Weight, Body) 03/2023 - 01/2023
2	Nausea 01/2023 - 01/2021
2	Vomiting 01/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2020
2	Meningitis 12/2022 - 03/2021
2	Bacterial Meningitis 12/2022 - 03/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2017
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2017
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022 - 10/2014
6	Immunoglobulin G (IgG)IBA 04/2024 - 01/2019
6	Transcription Factors (Transcription Factor)IBA 03/2023 - 05/2018
6	PolymersIBA 04/2021 - 01/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 04/2021 - 01/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2016
5	CholesterolIBA 01/2023 - 11/2007
5	CreatinineIBA 01/2023 - 01/2018
4	LipidsIBA 03/2024 - 01/2023
4	Nucleic AcidsIBA 01/2024 - 01/2020
4	AntigensIBA 03/2023 - 05/2021
4	Hemoglobins (Hemoglobin)IBA 02/2023 - 04/2020
4	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2020
4	Chimeric Antigen ReceptorsIBA 11/2022 - 01/2017
4	Therapeutic UsesIBA 11/2022 - 12/2009
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
3	LigandsIBA 04/2024 - 01/2018
3	CytokinesIBA 03/2024 - 01/2018
3	Opioid Analgesics (Opioids)IBA 03/2024 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2019
3	Rifampin (Rifampicin)FDA LinkGeneric 12/2023 - 01/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2021
3	SolutionsIBA 10/2023 - 11/2015
3	Serum AlbuminIBA 02/2023 - 01/2019
3	Amino Acids FDA Link 01/2023 - 08/2021
3	AlbuminsIBA 12/2022 - 07/2014
3	Indicators and Reagents (Reagents)IBA 12/2021 - 07/2018
3	Circular RNAIBA 01/2021 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 11/2017
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2019 - 01/2019
3	poly(gamma-glutamylglutamine)paclitaxelIBA 11/2017 - 01/2011
2	Thyroid HormonesIBA 12/2024 - 02/2019
2	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2018
2	Remifentanil (Ultiva)FDA Link 03/2024 - 11/2023
2	AntibodiesIBA 01/2024 - 01/2023
2	Streptomycin (Streptomycin Sulfate)FDA Link 11/2023 - 01/2021
2	SeleniumIBA 10/2023 - 03/2023
2	ChemokinesIBA 10/2023 - 01/2020
2	4-phenylbutyric acid (Buphenyl)FDA Link 10/2023 - 03/2023
2	ursodoxicoltaurineIBA 10/2023 - 03/2023
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2022
2	AntioxidantsIBA 01/2023 - 03/2021
2	Insulin (Novolin)FDA Link 01/2023 - 06/2017
2	polydopamineIBA 01/2023 - 08/2019
2	CollagenIBA 01/2023 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2022
2	MelatoninIBA 12/2022 - 03/2021

Therapy/Procedure

18	Therapeutics 12/2023 - 01/2011
4	Radiotherapy 07/2023 - 01/2018
3	General Anesthesia 03/2024 - 01/2021
2	Immunotherapy 04/2024 - 05/2021
2	Analgesia 03/2024 - 01/2023
2	Adjuvant Chemotherapy 05/2023 - 01/2023
2	Hysterectomy 01/2023 - 01/2021